Name | 3-(2-Aminoethyl)-1-{[(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl]ca rbonyl}-5-methoxy-1,3-dihydro-2H-benzimidazol-2-one |
---|---|
Synonyms | D-3263 |
Description | D-3263 is an agonist of transient receptor potential melastatin member 8 (TRPM8) with potential antineoplastic activity. |
---|---|
Related Catalog | |
In Vitro | D-3263 induces calcium flux and cell death in in vitro cells expressing TRPM8[1]. |
In Vivo | D-3263 (50 or 100 mg/kg/d) alone or with Finasteride (10 mg/kg/d) results in reduction in prostate hyperplasia of rats with evidence of a dose response. The highest dose of the TRPM8 agonist D-3263, given in combination with Finasteride, results in lower prostate weights than the highest dose of D-3263 or Finasteride given alone, suggesting a potential additive effect[1]. |
References |
Molecular Formula | C21H31N3O3 |
---|---|
Molecular Weight | 373.48900 |
Exact Mass | 373.23700 |
PSA | 79.25000 |
LogP | 3.81920 |
Storage condition | 2-8℃ |